BlackRock’s Biocept, Inc. BIOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-5,261
| Closed | -$6.58K | – | 5555 |
|
|
2023
Q3 | $6.58K | Hold |
5,261
| – | – | ﹤0.01% | 5225 |
|
|
2023
Q2 | $6.37K | Sell |
5,261
-3
| -0.1% | -$17 | ﹤0.01% | 5292 |
|
|
2023
Q1 | $53.7K | Hold |
5,264
| – | – | ﹤0.01% | 5102 |
|
|
2022
Q4 | $83.7K | Hold |
5,264
| – | – | ﹤0.01% | 5096 |
|
|
2022
Q3 | $145K | Hold |
5,264
| – | – | ﹤0.01% | 5065 |
|
|
2022
Q2 | $148K | Sell |
5,264
-1,385
| -21% | -$63.1K | ﹤0.01% | 5116 |
|
|
2022
Q1 | $463K | Buy |
6,649
+224
| +3% | +$17.6K | ﹤0.01% | 4894 |
|
|
2021
Q4 | $698K | Buy |
6,425
+46
| +0.7% | +$5.3K | ﹤0.01% | 4776 |
|
|
2021
Q3 | $767K | Sell |
6,379
-26
| -0.4% | -$3.03K | ﹤0.01% | 4634 |
|
|
2021
Q2 | $805K | Buy |
6,405
+17
| +0.3% | +$2.3K | ﹤0.01% | 4573 |
|
|
2021
Q1 | $975K | Hold |
6,388
| – | – | ﹤0.01% | 4509 |
|
|
2020
Q4 | $851K | Hold |
6,388
| – | – | ﹤0.01% | 4254 |
|
|
2020
Q3 | $845K | Sell |
6,388
-1,932
| -23% | -$390K | ﹤0.01% | 4151 |
|
|
2020
Q2 | $1.78M | Buy |
8,320
+8,232
| +9,355% | +$1.18M | ﹤0.01% | 3856 |
|
|
2020
Q1 | $8K | Hold |
88
| – | – | ﹤0.01% | 4738 |
|
|
2019
Q4 | $8K | Hold |
88
| – | – | ﹤0.01% | 4763 |
|
|
2019
Q3 | $22K | Hold |
88
| – | – | ﹤0.01% | 4639 |
|
|
2019
Q2 | $29K | Hold |
88
| – | – | ﹤0.01% | 4642 |
|
|
2019
Q1 | $30K | Hold |
88
| – | – | ﹤0.01% | 4549 |
|
|
2018
Q4 | $23K | Hold |
88
| – | – | ﹤0.01% | 4566 |
|
|
2018
Q3 | $73K | Hold |
88
| – | – | ﹤0.01% | 4501 |
|
|
2018
Q2 | $159K | Buy |
88
+1
| +1% | +$2.02K | ﹤0.01% | 4367 |
|
|
2018
Q1 | $230K | Buy |
87
+1
| +1% | +$3.75K | ﹤0.01% | 4181 |
|
|
2017
Q4 | $534K | Buy |
86
+1
| +1% | +$7.91K | ﹤0.01% | 4042 |
|
|
2017
Q3 | $940K | Hold |
85
| – | – | ﹤0.01% | 3931 |
|
|
2017
Q2 | $1.04M | Sell |
85
-1
| -1% | -$14.1K | ﹤0.01% | 3841 |
|
|
2017
Q1 | $1.65M | Buy |
+86
| New | +$1.46M | ﹤0.01% | 3711 |
|
BlackRock's BIOC Position: Q4 2023 in Review
BlackRock sold out of Biocept, Inc. (BIOC) in Q4 2023, closing a stake of 5,261 shares — an estimated $6.58K sold.
BlackRock first reported a position in BIOC in Q1 2017 and held it in 27 quarters. The position peaked at $1.78M in Q2 2020. 0 funds tracked by Wall St. Rank hold BIOC as of Q4 2023.
- BlackRock reported no remaining Biocept, Inc. position as of Q4 2023 after selling out during the quarter.
- BlackRock sold 5,261 Biocept, Inc. shares in Q4 2023, an estimated $6.58K.
- BlackRock first reported a position in Biocept, Inc. in Q1 2017 and held it in 27 quarters.
- BlackRock's Biocept, Inc. position peaked at $1.78M in Q2 2020.
- 0 funds tracked by Wall St. Rank held Biocept, Inc. as of Q4 2023.
Based on BlackRock's 13F filing for Q4 2023, filed 13 Feb 2024.